Levendoglu-Tugal Oya, Ozkaynak M Fevzi, LaGamma Edmund, Sherbany Ariel, Sandoval Claudio, Jayabose Somasundaram
Pediatric Hematology/Oncology, Westchester Medical Center-New York Medical College, Valhalla, New York 10595, USA.
J Pediatr Hematol Oncol. 2002 Jun-Jul;24(5):405-9. doi: 10.1097/00043426-200206000-00017.
Hemophagocytic lymphohistiocytosis (HLH) may present with thrombocytopenia during the newborn period. Three neonates (one term and two preterm) presented during the newborn period with thrombocytopenia. Transient recovery occurred in two newborns. The diagnosis of HLH was made after the recurrence of thrombocytopenia and the clinical symptoms at 5 and 7 weeks. The third infant was a premature baby diagnosed at 8 days of age after manifesting the clinical and laboratory features of HLH. All three neonates were treated with chemotherapy and responded well. After hematologic and clinical remission was achieved, the two newborns received hematopoietic stem cell transplantation from allogeneic donors. The third neonate is currently receiving chemotherapy. Persistent or recurrent thrombocytopenia of undetermined cause during the neonatal period should raise the suspicion of HLH, even though other symptoms or signs are not yet evident.
噬血细胞性淋巴组织细胞增生症(HLH)在新生儿期可能表现为血小板减少。三名新生儿(一名足月儿和两名早产儿)在新生儿期出现血小板减少。两名新生儿出现短暂恢复。血小板减少复发以及在5周和7周时出现临床症状后确诊为HLH。第三名婴儿是一名早产儿,在出现HLH的临床和实验室特征后于8日龄时被诊断。所有三名新生儿均接受化疗且反应良好。血液学和临床缓解后,两名新生儿接受了来自异基因供体的造血干细胞移植。第三名新生儿目前正在接受化疗。新生儿期原因不明的持续性或复发性血小板减少应引起对HLH的怀疑,即使其他症状或体征尚不明显。